Now That Mylan Lost A Quarter Of Its Value, The Chart Says To Look For A Bounce

Summary:

• Mylan NV MYL sank 24% on Tuesday after the company posted earnings that beat Wall Street expectations for earnings but missed on revenue.
• As this move is coming towards the end of its current market cycle, we expect a small bounce, but expect this to be followed by more downside risk.
• Shares were trading 2% higher on Wednesday.

Mylan Stock Weekly Chart

The company reported earnings per share of $0.82 and total revenue of $2.5 billion, compared to analyst estimates of $0.79 and $2.7 billion, respectively. Management also reaffirmed its guidance, which is in line with expectations.

Facing an array of problems, CEO Heather Bresch had announced a strategic review on which, “There is a tremendous amount of work being done.” However, she was unable to give an update or a specific date on which she would provide the results. This did not assuage investor concerns.

Our approach to stock analysis focuses on market cycles. It is clear to us that Mylan is towards the end the declining phase of its current cycle. This stock followed our analysis well, as you can see from the cycle patterns on the chart above. Our view is that a bottom is soon due, but that the subsequent bounce will likely be temporary given the stock's negative momentum.

Related Links:

The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs